Weight-Loss drug semaglutide put to the test: does it really burn more energy?
NCT ID NCT06390501
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study looked at how weekly injections of semaglutide (a GLP-1 drug) affect energy expenditure in 60 adults with obesity. Participants received either the drug or a placebo, plus a calorie-restricted diet. Researchers measured changes in total daily energy use, resting metabolism, and physical activity over 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY; DRUG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shenzhen Institute of Advanced Technology
Shenzhen, China
Conditions
Explore the condition pages connected to this study.